Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival
about
Circulating biomarkers to monitor cancer progression and treatmentClinical relevance of circulating cell-free microRNAs in ovarian cancerThe Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project.MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis
P2860
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Plasma miR-200b in ovarian car ...... n of progression-free survival
@ast
Plasma miR-200b in ovarian car ...... n of progression-free survival
@en
type
label
Plasma miR-200b in ovarian car ...... n of progression-free survival
@ast
Plasma miR-200b in ovarian car ...... n of progression-free survival
@en
prefLabel
Plasma miR-200b in ovarian car ...... n of progression-free survival
@ast
Plasma miR-200b in ovarian car ...... n of progression-free survival
@en
P2093
P2860
P50
P356
P1433
P1476
Plasma miR-200b in ovarian car ...... n of progression-free survival
@en
P2093
Anne-Sophie Jimenez-Pailhes
Catherine Uzan
Claire Gourzones-Dmitriev
Enrica Bentivegna
Gwénaël Le Teuff
Olivier Caron
Sébastien Gouy
P2860
P304
36815-36824
P356
10.18632/ONCOTARGET.5766
P407
P577
2015-11-01T00:00:00Z